Invited review: Treatment of cows with an extended postpartum anestrous interval.
Cows with an extended interval from calving to first ovulation (PPI) have increased intervals from calving to conception and are more likely to be culled compared with cows with a short PPI. In year-round calving dairy herds, between 11 and 38% of cows are reported as anestrus by 50 or 60 d after calving. In seasonally calving dairy herds, between 13 and 48% of cows are diagnosed as anovulatory anestrus at the start of the breeding period. Ovulation and estrus after calving are delayed when the positive feedback effects of estradiol on release of LH from the pituitary, and circulating concentrations of metabolic hormones such as insulin and insulin-like growth factor-I, are reduced by a variety of environmental factors. The main factors are limited energy intake, lower body reserves, increased partitioning of energy to milk production, suckling, and peripartum disease. Treatment options for cows with an extended PPI include hormonal and management strategies. Hormonal treatments that include a period of progesterone supplementation result in the majority of treated animals displaying estrus with a subsequent luteal phase of normal duration and improved pregnancy rates compared with untreated controls. Hormonal interventions also tend to have more predictable outcomes compared with management changes, such as manipulating body condition or dietary intakes after calving, and usually have some estrous synchronization effect, thus facilitating the use of artificial insemination. However, responses to any treatment are variable and are related to those factors that influence duration of the PPI, such as body condition and parity.
Rhodes
F M
FM
Dexcel Limited, Private Bag 3221, Hamilton, New Zealand. rhodesf@wave.co.nz
McDougall
S
S
Burke
C R
CR
Verkerk
G A
GA
Macmillan
K L
KL
D000780:Anestrus; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D001947:Breeding; D002417:Cattle / Q000502:physiology*; D002418:Cattle Diseases; D006063:Chorionic Gonadotropin / Q000008:administration & dosage; D015237:Dinoprost / Q000008:administration & dosage; D004958:Estradiol / Q000008:administration & dosage; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D008183:Luteal Phase; D010060:Ovulation; D010298:Parity; D049590:Postpartum Period; D011374:Progesterone / Q000008:administration & dosage; D012621:Seasons; D013997:Time Factors
D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D004958:Estradiol; D015237:Dinoprost